title: Factors associated with the length of remission of psoriasis vulgaris.
abstract: BACKGROUND
  Cardiovascular risk factors are found with significantly high frequency in psoriatic patients. Periods of remission and reactivation of lesions are common in psoriasis.
  
  
  OBJECTIVE
  Considering the association of chronic inflammation with the atherogenic process, we aimed to search for a possible relationship between the lipid profile, adipokine levels and body mass index (BMI) at the end of a successful treatment for psoriasis, and the length of remission of psoriasis.
  
  
  METHODS
  Forty-three patients were clinically and analytically studied after a successful treatment [as shown by Psoriasis Area and Severity Index (PASI)]--nine treated with topical agents, 17 with narrow-band UV light B (NB-UVB) and 17 with psoralen plus UVA-and were followed to record the length of remission.
  
  
  RESULTS
  The length of psoriasis remission correlated negatively and significantly with cholesterol levels, which correlated significantly and positively with C-reactive protein (CRP). In multiple linear regression analysis, cholesterol, CRP, PASI and BMI were associated with the length of remission. Patients with cholesterol levels <200 mg/dL (n = 13) presented a significantly longer remission, lower BMI and triglycerides values, and a trend towards lower PASI and CRP values than those with high cholesterol (n = 30). Considering patients according to the treatment used, cholesterol was also associated with length of remission, especially for patients treated with NB-UVB and topical therapy.
  
  
  CONCLUSIONS
  Psoriasis patients with the highest cholesterol levels presented higher BMIs, triglycerides levels and shorter remission periods. Our data suggest that the identification of potentially treatable conditions, such as dyslipidaemia and obesity, and their adequate treatment may benefit psoriasis patients by increasing the length of remission of the disease.
authors: Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Rua Campo Alegre 823, 4150, Porto, Portugal, ssn.coimbra@gmail.com.
authors: Susana
authors: S
authors: Coimbra
authors: Hugo
authors: H
authors: Oliveira
authors: Américo
authors: A
authors: Figueiredo
authors: Petronila
authors: P
authors: Rocha-Pereira
authors: Alice
authors: A
authors: Santos-Silva
mesh_terms: D000328:Adult; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000150:complications; D005260:Female; D005363:Ficusin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D005363:Ficusin
references: J Am Acad Dermatol. 2006 Apr;54(4):614-21
references: 16546581
references: Clin Chim Acta. 2001 Jan;303(1-2):33-9
references: 11163020
references: Atherosclerosis. 2006 Aug;187(2):415-22
references: 16257408
references: Am J Clin Dermatol. 2010 Dec 1;11(6):423-32
references: 20429617
references: Am J Cardiol. 2008 Apr 15;101(8):1119-26
references: 18394444
references: Acta Derm Venereol. 2008;88(6):561-5
references: 19002339
references: J Dermatol Sci. 2009 Sep;55(3):202-4
references: 19576730
references: Dermatol Ther. 2010 Jan-Feb;23 Suppl 1:S14-9
references: 20136916
references: Dermatology. 2005;211(2):103-6
references: 16088154
references: Atherosclerosis. 2005 Dec;183(2):308-15
references: 16285994
references: Diabetes Obes Metab. 2007 May;9(3):218-32
references: 17391148
references: Dermatology. 2008;217(4):365-73
references: 18810241
references: Med Clin North Am. 2011 Sep;95(5):893-902
references: 21855698
references: J Eur Acad Dermatol Venereol. 2010 Jul;24(7):789-96
references: 20002653
references: Br J Dermatol. 2007 Oct;157(4):649-55
references: 17627791
references: J Eur Acad Dermatol Venereol. 2010 Dec;24(12):1386-94
references: 20337818
references: J Eur Acad Dermatol Venereol. 2004 Mar;18(2):180-3
references: 15009298
references: Br J Dermatol. 2004 May;150(5):917-28
references: 15149504
references: Am J Clin Dermatol. 2013 Feb;14(1):49-53
references: 23329079